SFM
Sphera Funds Management Portfolio holdings
AUM
$479M
1-Year Est. Return
66.44%
This Fund
S&P 500
1 Year Est. Return
+66.44%
AUM
$479M
AUM Growth
+$56.9M
(+14%)
Holding
128
Top Buys
| 1 | +$9.19M | |
| 2 | +$8M | |
| 3 | +$7.87M | |
| 4 |
Vor Biopharma
VOR
|
+$7.64M |
| 5 |
Oric Pharmaceuticals
ORIC
|
+$6.59M |
Top Sells
| 1 | +$19M | |
| 2 | +$18.2M | |
| 3 | +$13.8M | |
| 4 |
Praxis Precision Medicines
PRAX
|
+$10.8M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$9.45M |
Sector Composition
| 1 | Healthcare | 85.98% |
| 2 | Technology | 11.47% |
| 3 | Industrials | 1.25% |
| 4 | Communication Services | 0% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Celldex Therapeutics
CLDX
$2B
| $6.51M | 1.36% |
239,764
+32,000
|
|
||
27
Soleno Therapeutics
SLNO
$2.1B
| $6.31M | 1.32% |
136,314
+94,708
|
|
||
28
Apellis Pharmaceuticals
APLS
$2.68B
| $6.3M | 1.32% |
250,961
+187,301
|
|
||
29
GSK
GSK
$119B
| $5.98M | 1.25% |
122,000
|
|
||
30
Enphase Energy
ENPH
$5.54B
| $5.98M | 1.25% |
186,500
+159,800
|
|
||
31
Novo Nordisk
NVO
$166B
| $5.89M | 1.23% |
115,677
+10,000
|
|
||
32
Cytokinetics
CYTK
$7.61B
| $5.83M | 1.22% |
91,717
-69,800
|
|
||
33
AbbVie
ABBV
$410B
| $5.77M | 1.21% |
25,256
|
|
||
34
SolarEdge
SEDG
$2.14B
| $5.67M | 1.18% |
196,536
+55,570
|
|
||
35
Acadia Pharmaceuticals
ACAD
$4.16B
| $5.67M | 1.18% |
212,202
+63,302
|
|
||
|
36
Vor Biopharma
VOR
$641M
| $5.37M | 1.12% |
+410,417
|
|
||
37
Merck
MRK
$306B
| $5.12M | 1.07% |
48,600
|
|
||
38
Novartis
NVS
$322B
| $5.1M | 1.07% |
37,000
|
|
||
39
Forte Biosciences
FBRX
$379M
| $5.07M | 1.06% |
185,869
-288,440
|
|
||
40
Kodiak Sciences
KOD
$1.64B
| $4.91M | 1.03% |
+175,500
|
|
||
41
Tango Therapeutics
TNGX
$1.5B
| $4.82M | 1.01% |
+544,563
|
|
||
|
ATXS
42
DELISTED
Astria Therapeutics
ATXS
| $4.66M | 0.97% |
355,725
+104,500
|
|
||
43
MediWound
MDWD
$222M
| $4.25M | 0.89% |
230,347
+45,077
|
|
||
44
Camtek
CAMT
$7.66B
| $4.2M | 0.88% |
39,498
+10,450
|
|
||
45
Revolution Medicines
RVMD
$19.7B
| $4.18M | 0.87% |
52,500
-7,500
|
|
||
46
Advanced Micro Devices
AMD
$326B
| $3.86M | 0.81% |
18,040
+2,570
|
|
||
|
CLYM
47
Climb Bio
CLYM
$488M
| $3.73M | 0.78% |
932,247
+497,410
|
|
||
|
ACOG
48
Alpha Cognition
ACOG
$130M
| $3.69M | 0.77% |
567,616
+228,864
|
|
||
49
Enliven Therapeutics
ELVN
$1.76B
| $3.49M | 0.73% |
226,765
+60,000
|
|
||
50
Protara Therapeutics
TARA
$341M
| $3.46M | 0.72% |
+650,000
|
|